The impact of the molecular genetic test on the diagnosis delay and outcome in patients with pulmonary tuberculosis

Journal Title: Moldovan Medical Journal - Year 2018, Vol 61, Issue 3

Abstract

Background: The aim of the study was the assessment of the impact of the molecular genetic Xpert MTB/Rif assay on the diagnostic delay and the treatment effectiveness in pulmonary tuberculosis, according to the results of the microbiological and molecular-genetic methods, in order to optimize the management of the drug resistant tuberculosis. Material and methods: A retrospective selective study, which included 226 patients with multidrug-resistant pulmonary tuberculosis (study sample) and 78 patients with drug-susceptible pulmonary tuberculosis (control group), was performed. Patients were divided into 2 subgroups following the results of the molecular-genetic and bacteriological investigations. The study sample was divided in two groups: the 1st group included 85 patients enrolled in the treatment for drug resistant tuberculosis, according to the results of the Xpert MTB test and the 2nd group included 141 patients enrolled in the treatment DOTS plus, according to the results of the conventional cultures. Results: The impact of the molecular genetic GeneXpert MTB/Rif assay was demonstrated on early diagnosis, adequate treatment according to the drug susceptibility to rifampicin, shorter duration of the treatment, low rate of the side events, optimal treatment compliance and higher treatment effectiveness. The conventional microbiological methods contributed to the late diagnosis of the patients, high rate of the severe and complicated tuberculosis, long duration of the treatment which were reflected on the low treatment effectiveness. However the conventional culture methods allowed the treatment individualization according to the drug susceptibility tests. Conclusions: Target screening of the population with risks and compulsory investigation by GeneXpert MTB/Rif assay will diminish the rate of severe late detected forms of pulmonary tuberculosis and adapt the treatment according to the drug resistance to rifampicin.

Authors and Affiliations

Alina Malic

Keywords

Related Articles

An efficient procedure of isolation, cultivation and identification of bone marrow mesenchymal stem cells

Background: Bone marrow mesenchymal stem cells (MSC) have a wide application in domain of Regenerative Medicine. Of a great importance is utilization of a suitable bone marrow extraction technique that can provide a suff...

Fetal and neonatal complications of diabetic pregnancy

Background: There is currently convincing clinical and experimental evidence that a hyperglycemic intrauterine environment is responsible not only for significant short-term outcomes in the fetus and newborn infant, but...

Challenging issues of tuberculosis control in the Russian Federation

Background: The comparative assessment of the epidemiological indices and challenging issues of the tuberculosis control in the Russian Federation. Material and methods: In the study were used the analytical annual repor...

Usage of cardiotonic drugs at the intensive care units

Background: Circulation insufficiency is one of the most common dysfunctions in the patients admitted to the intensive care units (ICU) [1]. These patients need an intravenous (IV) vasoactive drug administration to optim...

Postoperative cognitive dysfunction: physiopathological aspects and clinical evidence

Background: Postoperative cognitive dysfunction (POCD) represents a decrease of cognitive abilities (memory, learning, concentration), which develops in the postoperative period after a variable amount of time (days or w...

Download PDF file
  • EP ID EP480538
  • DOI 10.5281/zenodo.1299018
  • Views 304
  • Downloads 0

How To Cite

Alina Malic (2018). The impact of the molecular genetic test on the diagnosis delay and outcome in patients with pulmonary tuberculosis. Moldovan Medical Journal, 61(3), 3-9. https://europub.co.uk/articles/-A-480538